IFNA17 and metastatic melanoma: We have performed a prospective randomized trial in patients with metastatic melanoma treated either with a chemotherapy regimen of cisplatin, carmustine, dacarbazine, and tamoxifen, or with the identical chemotherapy followed by outpatient s.c. IL-2 and s.c. IFN-α.